Medical teams are preparing to begin offering Lecanemab with FDA approval expected soon. Read about the benefits along with some of the potential issues here.
Lecanemab Alzheimer’s Treatment Set for FDA Approval
Share This Story, Choose Your Platform!
About the Author: Gary Skole
Gary has a degree in business management from the University of Massachusetts. He has been the owner of a private duty home care agency since 1989 and continues as a partner in Home to Stay Healthcare Solutions in Cherry Hill NJ. He sits on a committee with the Home Care Association of America and speaks at national conferences on the subject of dementia.
Gary is also the founder and CEO of AlzBetter, a company which was created to address the needs of people living with dementia and offer support to those who care for them. He has authored several books and a video educational series on dementia care. Additionally, he has been recognized as a dementia leader and innovator winning the 2024 inaugural Home Health News Memory Care Innovation Award and CEO Monthly Magazine's Most Influential CEO Awards 2024
Leave A Comment